期刊文献+

阿司匹林与心脑血管疾病 被引量:8

Aspirin,Cardiovascular and Cerebrovascular Diseases
下载PDF
导出
摘要 心脑血管疾病为人类死亡原因之首,其预防与治疗始终为医学关注的焦点。阿司匹林作为心脑血管疾病的防治疗药物已经有一个世纪之久,是历史最长,同时也是用量最多的药物。每年大约有1000亿片阿司匹林被用于解热镇痛和心脑血管疾病。人们对阿司匹林的研究和认识还在不断加深,如阿司匹林抵抗的出现以及阿司匹林水解酶的鉴定。本文综述了阿司匹林在心脑血管疾病预防方面的研究热点以及未来的研究方向,主要包括阿司匹林抵抗以及个体化用药。 Cardiovascular and cerebrovascular diseases is the most fatal diseases in the world.The prevention and treatment of cardiovascular and cerebrovascular diseases are both basic and clinical focus.Aspirin has been used as a prevention medicine in cardiovascular and cerebrovascular diseases for over a century, which is the longest one in history.Aspirin use is estimated at 100 billion tablets annually as an analgesic, antipyretic and antiplatelet drugs.However, there are still many new findings about aspirin, such as aspirin resistance and aspirin hydrolase.This paper reviews the current research advances and future directions of aspirin in cardiovascular and cerebravascwlar diseases, mainly focuses on aspirin resistance and personalized medication.
出处 《中国生化药物杂志》 CAS 2015年第7期172-174,177,共4页 Chinese Journal of Biochemical Pharmaceutics
关键词 阿司匹林 阿司匹林抵抗 心脑血管病 个体化用药 药物遗传学 aspirin aspirin resistance cardiovascular and cerebrovascular diseases personalized medication pharmacogenomics
  • 相关文献

参考文献20

  • 1Nauder Faraday,Diane M Becker,Lewis C Becker.Pharmacogenomics of platelet responsiveness to aspirin[J]. Pharmacogenomics . 2007 (10)
  • 2Paul A. Gurbel,Kevin P. Bliden,Joseph DiChiara,Justin Newcomer,Willy Weng,Nagaraj K. Neerchal,Tania Gesheff,Srivasavi K. Chaganti,Amena Etherington,Udaya S. Tantry.Evaluation of Dose-Related Effects of Aspirin on Platelet Function: Results From the Aspirin-Induced Platelet Effect (ASPECT) Study[J]. Circulation . 2007 (25)
  • 3Nauder Faraday,Lisa R. Yanek,Rasika Mathias,J Enrique Herrera-Galeano,Dhananjay Vaidya,Taryn F. Moy,M Daniele Fallin,Alexander F. Wilson,Paul F. Bray,Lewis C. Becker,Diane M. Becker.Heritability of Platelet Responsiveness to Aspirin in Activation Pathways Directly and Indirectly Related to Cyclooxygenase-1[J]. Circulation . 2007 (19)
  • 4Sidney C. Smith,Jerilyn Allen,Steven N. Blair,Robert O. Bonow,Lawrence M. Brass,Gregg C. Fonarow,Scott M. Grundy,Loren Hiratzka,Daniel Jones,Harlan M. Krumholz,Lori Mosca,Richard C. Pasternak,Thomas Pearson,Marc A. Pfeffer,Kathryn A. Taubert.AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute[J]. Circulation . 2006 (19)
  • 5Philip B. Gorelick,Steven M. Weisman.Risk of Hemorrhagic Stroke With Aspirin Use: An Update[J]. Stroke . 2005 (8)
  • 6Victor L. Serebruany,Steven R. Steinhubl,Peter B. Berger,Alex I. Malinin,Jeffrey S. Baggish,Deepak L. Bhatt,Eric J. Topol.Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials[J]. The American Journal of Cardiology . 2005 (10)
  • 7Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients: A role of plasma esterases[J]. BBA - General Subjects . 2005 (2)
  • 8High-dose aspirin in addition to daily low-dose aspirin decreases platelet activation in patients before and after percutaneous coronary intervention[J]. Thrombosis Research . 2002 (5)
  • 9Charles H. Hennekens,Mark L. Dyken,Valentin Fuster.Aspirin as a Therapeutic Agent in Cardiovascular Disease: A Statement for Healthcare Professionals From the American Heart Association[J]. Circulation . 1997 (8)
  • 10David B Jack.One hundred years of aspirin[J]. The Lancet . 1997 (9075)

共引文献3

同被引文献58

引证文献8

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部